oncology
The new paradigm in oncology drug marketing
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology
Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …
Boehringer and Ventana link up
September 24, 2013Research and Development, Sales and Marketing Boehringer, Ventana, oncology
Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …
Bayer partners with US academics
September 13, 2013Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology
Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
Astellas hires senior VP from rival Takeda
August 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology
Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
Pfizer abandons cancer trial
May 22, 2013Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology
Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …
Swiss Re helps Roche open up China’s oncology market
December 17, 2012Sales and Marketing Cancer, China, Roche, Swiss re, oncology
Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …
Novartis blood cancer hope
December 12, 2012Research and Development, Sales and Marketing Jakavi, Novartis, oncology
Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …
Lilly suffers late-stage cancer blow
September 10, 2012Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology
Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …
Merck KGaA licences new cancer candidate
September 10, 2012Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology
Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …
GSK submits melanoma drugs for regulatory approval
August 3, 2012Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology
GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …
Boehringer collaborates with Havard
July 9, 2012Research and Development, Sales and Marketing Boehringer, Havard, oncology, research deal
Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …
New director of market access at Celgene UK and Ireland
June 18, 2012Business Services, Medical Communications, Sales and Marketing Celgene, Nicola Redfern, oncology
Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …
Lilly app aims to boost trial recruitment
June 8, 2012Medical Communications GSK, clinical trials, lilly, oncology
Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …
New cancer drug costs escalating for NHS
December 13, 2011Cancer, NHS, oncology
New oncology drugs are pushing up the overall costs of treating cancer, according to a new report. The ‘Cancer Diagnosis …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
